tiprankstipranks
Advertisement
Advertisement
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
PremiumWeekend UpdatesCTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
1M ago
CytomX Earnings Call: Varseta‑M Drives Long Runway
Premium
Company Announcements
CytomX Earnings Call: Varseta‑M Drives Long Runway
1M ago
CytomX Therapeutics initiated with an Outperform at Wolfe Research
Premium
The Fly
CytomX Therapeutics initiated with an Outperform at Wolfe Research
1M ago
CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)
PremiumThe FlyCytomX Therapeutics reports Q1 EPS (10c), consensus (11c)
2M ago
CytomX Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
CytomX Therapeutics participates in a conference call with JPMorgan
3M ago
CytomX Therapeutics Signals Progress in Varseta-M Trial
Premium
Company Announcements
CytomX Therapeutics Signals Progress in Varseta-M Trial
3M ago
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
PremiumThe FlyCytomX Therapeutics price target raised to $16 from $8 at Jefferies
3M ago
CytomX Therapeutics price target raised to $15 from $10 at Guggenheim
Premium
The Fly
CytomX Therapeutics price target raised to $15 from $10 at Guggenheim
3M ago
CytomX Therapeutics 45.9M share Secondary priced at $5.30
Premium
The Fly
CytomX Therapeutics 45.9M share Secondary priced at $5.30
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100